Sarda Proteins Ltd
₹ 74.1
-5.00%
29 Dec
- close price
- Market Cap ₹ 12.8 Cr.
- Current Price ₹ 74.1
- High / Low ₹ 144 / 60.0
- Stock P/E
- Book Value ₹ 13.2
- Dividend Yield 0.00 %
- ROCE 0.84 %
- ROE 0.42 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company's working capital requirements have reduced from 256 days to 34.0 days
Cons
- Stock is trading at 5.61 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 0.00% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.47 | 5.02 | 2.06 | 6.18 | 5.65 | 7.22 | 5.40 | 11.36 | 10.76 | 5.80 | 1.30 | 24.19 | 39.30 | |
| 2.60 | 5.14 | 2.18 | 6.35 | 6.00 | 7.33 | 5.31 | 11.38 | 10.50 | 5.95 | 1.45 | 24.17 | 39.50 | |
| Operating Profit | -0.13 | -0.12 | -0.12 | -0.17 | -0.35 | -0.11 | 0.09 | -0.02 | 0.26 | -0.15 | -0.15 | 0.02 | -0.20 |
| OPM % | -5.26% | -2.39% | -5.83% | -2.75% | -6.19% | -1.52% | 1.67% | -0.18% | 2.42% | -2.59% | -11.54% | 0.08% | -0.51% |
| 0.00 | 0.80 | 0.00 | 0.00 | -0.01 | 0.03 | 0.08 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.11 | |
| Interest | 0.01 | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.17 | 0.62 | -0.17 | -0.19 | -0.37 | -0.09 | 0.17 | 0.06 | 0.35 | 0.01 | 0.02 | 0.02 | -0.09 |
| Tax % | -29.41% | 4.84% | -5.88% | -31.58% | -10.81% | 44.44% | 82.35% | 133.33% | 14.29% | 500.00% | 0.00% | 100.00% | |
| -0.12 | 0.59 | -0.15 | -0.13 | -0.33 | -0.12 | 0.03 | -0.02 | 0.31 | -0.03 | 0.02 | 0.01 | -0.10 | |
| EPS in Rs | -0.37 | 1.80 | -0.87 | -0.75 | -1.91 | -0.70 | 0.17 | -0.12 | 1.80 | -0.17 | 0.12 | 0.06 | -0.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 35% |
| 3 Years: | 31% |
| TTM: | 3175% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -20% |
| 3 Years: | -68% |
| TTM: | -267% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 51% |
| 3 Years: | -7% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 3% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.43 | 2.43 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Reserves | -0.29 | 0.30 | 0.15 | 0.02 | -0.31 | -0.44 | -0.41 | -0.43 | -0.12 | -0.15 | -0.13 | -0.13 | -0.22 |
| 0.32 | 0.21 | 0.61 | 0.20 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | |
| 0.13 | 0.20 | 0.21 | 0.20 | 0.13 | 0.12 | 0.06 | 0.07 | 0.07 | 0.05 | 0.07 | 0.28 | 84.69 | |
| Total Liabilities | 2.59 | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 |
| 0.50 | 0.10 | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.70 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.39 | 3.03 | 3.40 | 2.86 | 2.28 | 2.17 | 2.14 | 2.13 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 | |
| Total Assets | 2.59 | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.65 | 87.13 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.12 | -0.72 | -1.20 | -0.09 | 0.48 | -0.59 | -0.05 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | |
| -0.10 | 1.90 | 0.20 | 0.00 | 0.02 | 0.11 | 0.09 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | |
| 0.25 | -0.13 | 0.37 | -0.42 | -0.20 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| Net Cash Flow | 0.03 | 1.05 | -0.63 | -0.51 | 0.30 | -0.47 | 0.03 | 0.03 | 0.19 | -0.14 | -0.07 | -0.08 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8.87 | 13.81 | 0.00 | 38.98 | 44.58 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 92.42 | 32.70 | 324.22 | 64.41 | 28.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 3.13 | 0.76 | 0.00 | 0.61 | 0.00 | |||||||
| Cash Conversion Cycle | 98.16 | 45.75 | 324.22 | 102.78 | 73.22 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 50.24 | 65.44 | 251.60 | 108.08 | 76.23 | 83.92 | 114.91 | 55.91 | 64.45 | 130.27 | 603.65 | 33.95 |
| ROCE % | -6.72% | -5.93% | -4.52% | -6.02% | -14.66% | -5.63% | 8.17% | 2.88% | 15.73% | 0.42% | 0.85% | 0.84% |
Documents
Announcements
- Closure of Trading Window 2d
-
Announcement under Regulation 30 (LODR)-Change in Management
8 Dec - Three Additional Directors appointed for five-year terms from 8 Dec 2025 to 7 Dec 2030.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 08-12-2025
8 Dec - Appointed three Additional Directors for five-year terms; members' approval pending (08-Dec-2025).
-
Results - Financial Results Sept 2025
29 Nov - Unaudited Q2/H1 results (30 Sep 2025): H1 revenue Rs1,536.46 lakh; H1 loss Rs8.88 lakh; auditor review clean.
-
Board Meeting Outcome for Outcome Of Board Meeting
29 Nov - Unaudited Q2/H1 results to 30-Sep-2025: H1 revenue Rs1,536.46L; H1 loss Rs8.88L; auditor reviewed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
a) SPL used to deal in the protein products
and various other food products.
b) However, on 4th Sept 2024, the company resolved to switch its business to Power Industry for solar cell manufacturing and to deal
into dealing with all the machinery, instruments, and equipment for solar cell manufacturing
and solar power generation.
c) Hence, the company changed and
added a business objective to deal with
the renewable energy sector and solar
cell products.
d) Currently, it has core expertise in solar plant services, carbon-credit markets, intelligent asset management, and advanced automation technologies.